Bioidentical Hormones - U.S. Senate Special Committee on Aging
Bioidentical Hormones - U.S. Senate Special Committee on Aging
Bioidentical Hormones - U.S. Senate Special Committee on Aging
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
151<br />
WHITE PAPER #3<br />
RECENT ADVANCES IN QUALITY PHARMACY COMPOUNDING<br />
In the past, Compounding Was Pharmacy! Throughout history, pharmacists have<br />
compounded drugs for individualized dosages for patients when they were prescribed by<br />
physicians. In the early 1900s however, the pharmaceutical industry began manufacturing<br />
a myriad of drugs and dosage forms for patients and the need for compounding<br />
diminished. Since the late 1900s however, a lot has changed and the pharmaceutical<br />
industry no l<strong>on</strong>ger supplies all the medicati<strong>on</strong>s needed by patients. Pharmacy<br />
compounding has experienced tremendous growth. It has not, however, been without its<br />
detractors. True, there have been some difficulties al<strong>on</strong>g the way, but recently great<br />
strides have been made to enhance the quality of pharmacy compounding, including the<br />
following:<br />
PHARMACY COMPOUNDING ACCREDITATION BOARD<br />
A c<strong>on</strong>sortium of eight nati<strong>on</strong>al pharmacy organizati<strong>on</strong>s have worked together to estallish<br />
the Pharmacy Compounding Accreditati<strong>on</strong> Board. Operating through the offices of the<br />
Nati<strong>on</strong>al Associati<strong>on</strong> of Boards of Pharmacy, this board began the process of accrediting<br />
compounding pharmacies in the spring of 2005. The accreditati<strong>on</strong> standards are rigid and<br />
require comprehensive documentati<strong>on</strong> of a quality operati<strong>on</strong>. Although voluntary, there<br />
are potentially some distinct advantages to becoming an accredited compounding<br />
pharmacy.<br />
US. PRARMAMcPFYA-At T AIf?.iA Fnred ,f tF A DV<br />
Beginning in 1985 at the U.S. Pharmacopoeial C<strong>on</strong>venti<strong>on</strong>, a resoluti<strong>on</strong> regarding<br />
pharmacy compounding was passed, and this has been followed by resoluti<strong>on</strong>s at the<br />
1990, 1995, 2000, and the 2005 c<strong>on</strong>venti<strong>on</strong>s c<strong>on</strong>cerning increased efforts in establishing<br />
pharmacy compounding standards and especially efforts related to special populati<strong>on</strong>s<br />
(pediatrics). In recent years, two enforceable general chapters have been implemented,<br />
including USP Chapter Pharmaceutical Compounding--N<strong>on</strong>sterile Preparati<strong>on</strong>s,<br />
and USP Chapter Pharmaceutical Compounding-Sterile Preparati<strong>on</strong>s. In<br />
additi<strong>on</strong>, two additi<strong>on</strong>al USP informati<strong>on</strong>al chapters are in effect, including, USP Chapter<br />
Good Compounding Practices, and USP Chapter Pharmaceutical<br />
Calculati<strong>on</strong>s in Prescripti<strong>on</strong> Compounding. A new chapter <strong>on</strong> Quality C<strong>on</strong>trol in<br />
Pharmacy Compounding has been prepared. In additi<strong>on</strong> to the General Chapters,<br />
the USP-NF currently c<strong>on</strong>tains approximately 225 m<strong>on</strong>ographs related to pharmacy<br />
compounded preparati<strong>on</strong>s.<br />
U.S. PHARMACOPEIA-PHARMACISTS PHARMACOPEIA<br />
The U.S. Pharmacopeia was originally developed for pharmacists. However, the<br />
emphasis of the current USP-NF is directed towards the pharmaceutical industry. The<br />
USP-Pharmacists Pharmnacopeia was launched in the summer of 2005. This set of